While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here are two cash-producing companies that reinvest wisely to drive long-term success and one that may face some trouble.
One Stock to Sell:
Microchip Technology (MCHP)
Trailing 12-Month Free Cash Flow Margin: 18.8%
Spun out from General Instrument in 1987, Microchip Technology (NASDAQ: MCHP) is a leading provider of microcontrollers and integrated circuits used mainly in the automotive world, especially in electric vehicles and their charging devices.
Why Should You Sell MCHP?
- Annual sales declines of 3.8% for the past five years show its products and services struggled to connect with the market during this cycle
- Sales were less profitable over the last five years as its earnings per share fell by 17.7% annually, worse than its revenue declines
- Free cash flow margin shrank by 15.9 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive
At $65.44 per share, Microchip Technology trades at 27x forward P/E. Check out our free in-depth research report to learn more about why MCHP doesn’t pass our bar.
Two Stocks to Buy:
The Trade Desk (TTD)
Trailing 12-Month Free Cash Flow Margin: 27%
Built as an alternative to "walled garden" advertising ecosystems, The Trade Desk (NASDAQ: TTD) provides a cloud-based platform that helps advertisers and agencies plan, manage, and optimize digital advertising campaigns across multiple channels and devices.
Why Are We Backing TTD?
- Market share has increased as its 22% annual revenue growth over the last two years was exceptional
- Fast payback periods on sales and marketing expenses allow the company to invest heavily and onboard many customers concurrently
- Highly efficient business model is illustrated by its impressive 20.3% operating margin, and its operating leverage amplified its profits over the last year
The Trade Desk is trading at $22.05 per share, or 3.3x forward price-to-sales. Is now the right time to buy? Find out in our full research report, it’s free.
Eli Lilly (LLY)
Trailing 12-Month Free Cash Flow Margin: 13.8%
Founded in 1876 by a Civil War veteran and pharmacist frustrated with the poor quality of medicines, Eli Lilly (NYSE: LLY) discovers, develops, and manufactures pharmaceutical products for conditions including diabetes, obesity, cancer, immunological disorders, and neurological diseases.
Why Should You Buy LLY?
- Impressive 38.2% annual revenue growth over the last two years indicates it’s winning market share this cycle
- Adjusted operating margin improvement of 21.2 percentage points over the last two years demonstrates its ability to scale efficiently
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 25% exceeded its revenue gains over the last five years
Eli Lilly’s stock price of $935.57 implies a valuation ratio of 27x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
